Drug Safety

Post-Marketing Surveillance and Vigilance for Medical Devices: The European Approach
pp. 869-872(4)
Author: Randall H.

Hepatotoxicity with Thiazolidinediones: Is it a Class Effect?
pp. 873-888(16)
Author: Scheen A.J.

Drug-Induced Congenital Defects: Strategies to Reduce the Incidence
pp. 889-901(13)
Authors: de Santis M.; Carducci B.; Cavaliere A.F.; de Santis L.; Straface G.; Caruso A.

A Comparison of Liposomal Formulations of Doxorubicin with Drug Administered in Free Form: Changing Toxicity Profiles
pp. 903-920(18)
Authors: Waterhouse D.N.; Tardi P.G.; Mayer L.D.; Bally M.B.

Medication Overuse Headache: A Focus on Analgesics, Ergot Alkaloids and Triptans
pp. 921-927(7)
Authors: Katsarava Z.; Diener H-C.; Limmroth V.

Long Term Follow-Up Studies of Users of Nonprescription Medicines Purchased from Community Pharmacies: Some Methodological Issues
pp. 929-938(10)
Authors: Sinclair H.K.; Bond C.M.; Hannaford P.C.